大气和室温等离子体的近期进展作为一种新的和有前途的突变发生技术
Dongao Li1,2, Jie Shen1, Qiang Ding3
1Institute of Plasma Physics, HFIPS, Chinese Academy of Sciences, Low Temperature Plasma Application Laboratory, Hefei, China.
Cell biochemistry and function
|March 27, 2024
概括
大气和室温等离子体 (ARTP) 为微生物提供了一种绿色,快速的突变发生法. 这项技术诱导了DNA损伤以选优异的微生物突变,显示了微生物学中的巨大潜力.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 血科学是一门科学课.
背景情况:
- 大气和室温等离子体 (ARTP) 是一种新兴的突变发生技术.
- ARTP提供了诸如环保,温和的操作条件和快速突变发生等优势.
- 它通过诱导对生物体的物理,化学和电磁作用来起作用,从而导致DNA受损.
研究的目的:
- 系统地审查ARTP突变发生在各种应用领域的最新进展.
- 确定和总结与ARTP技术相关的当前瓶和挑战.
- 为ARTP在微生物突变发生过程中的更广泛应用提供理论基础和技术支持.
主要方法:
- 关于ARTP突变发生的最新科学文献的综述.
- 对ARTP对微生物DNA,酶和蛋白质的作用机制的分析.
- 对ARTP在微生物学中的应用及其与传统方法相结合的研究结果的综合.
主要成果:
- ARTP有效诱导核酸破裂,转换或逆转,导致DNA损伤.
- 这种DNA损伤有助于选具有增强生物特性的微生物突变.
- 由于其潜力,ARTP及其与传统方法的结合在微生物学中越来越多地被使用.
结论:
- ARTP是一种强大而有前途的微生物应用的突变发生技术.
- 解决目前的瓶对于优化ARTP的应用和潜力至关重要.
- 需要进一步的研究和开发,以充分利用ARTP改善微生物菌株.
相关概念视频
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
Mutations
37.2K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
37.2K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K


